Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 623,516	$ (349,248)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Income earned on investments held in Trust Account	(664,973)	(28,006)
Interest on mandatorily redeemable ordinary shares liability	(192,049)
Change in fair value of warrant liability	(2,188,800)	(2,872,800)
Loss on initial issuance of private warrants		2,599,200
Change in fair value of conversion option liability	(6,892)
Amortization of debt discount	16,901
Transaction costs allocated to warrant liabilities		30,212
Changes in operating assets and liabilities:
Prepaid expenses	(126,252)	(116,536)
Accounts payable and accrued expenses	600,588	43,569
Net cash used in operating activities	(1,937,961)	(693,609)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(3,041,666)	(139,380,000)
Cash withdrawn from Trust Account in connection with redemption	41,824,292
Net cash provided by (used in) investing activities	38,782,626	(139,380,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid		135,600,000
Proceeds from sale of Private Placement Warrants		5,130,000
Advances from related party		25,000
Repayment of advances from related party		(55,000)
Proceeds from convertible promissory note – related party	1,535,000
Proceeds from simple promissory note – related party	2,971,667
Repayment of promissory note – related party		(125,000)
Payment of offering costs		(416,260)
Redemption of ordinary shares	(41,824,292)
Net cash (used in) provided by financing activities	(37,317,625)	140,158,740
Net Change in Cash	(472,960)	85,131
Cash – Beginning of period	507,921	30,511
Cash – End of period	34,961	115,642
Non-Cash investing and financing activities:
Deferred underwriting fee payable		$ 5,190,000